| ²é¿´: 787 | »Ø¸´: 1 | ||
Drericchouгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
µÚÒ»´ÎͶSCI£¬ÊÕµ½ÈçÏ»ظ´£¬Çë¸÷λ°ïæ¿´¿´ÈçºÎÓ¦¶Ô¡£ÒÑÓÐ1È˲ÎÓë
|
|
Thank you for submitting your manuscript entitled "XXXX" to PLOS ONE. Your manuscript files have been checked in house but before we can proceed, we need you to address the following issues: 1) Please indicate in your methods section, and in the ¡®ethics¡¯ field in the submission system (via Edit Submission) whether written informed consent was given by participants (or next of kin/caregiver in the case of children) for their clinical records to be used in this study. If consent was not obtained please indicate whether patient records/information was anonymized and de-identified prior to analysis. ¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª¡ª µÚÒ»´ÎͶSCI£¬ÔÓÖ¾ÊÇPLOS ONE£¬ÄÚÈÝÊÇһƪÏû»¯µÀÖ×ÁöÊõǰ»¯ÁƵĻعËÐÔ·ÖÎö£¬±»±à¼ÒªÇó×÷³öÈçÏ´𸴡£ ÊÂʵÉÏ£¬Ã»ÓÐwritten informed consent£¬Ò²Ã»ÓÐanonymized and de-identified prior to analysis£¬ÎÒ¸ÃÈçºÎ»Ø´ð¡£Êµ»°ÊµËµ£¬»¹ÊÇ¡¡£¿ Çó¸÷λָµã£¬¸ÃÈçºÎÓ¦¶Ô£¬Èç¹ûʵ»°ÊµËµ£¬»á²»»áÓ°Ïì±à¼¶Ô±¾ÎĵÄÓ¡Ïóµ¼ÖÂÎÞ·¨·¢±í£¿ СµÜÔÚ´Ëл¹ý¸÷λ£¡ |
» ²ÂÄãϲ»¶
µ½Ðµ¥Î»ºó£¬»»ÁËеÄÑо¿·½Ïò£¬Ã»ÓÐÍŶӣ¬³ÖÐø»ýÀÛ2ÇøÒÔÉÏÂÛÎÄ£¬ÄÜÉêÇëµ½ÃæÉÏÂð
ÒѾÓÐ5È˻ظ´
2025ÀäÞøÑ§Ê²Ã´Ê±ºò³ö½á¹û
ÒѾÓÐ7È˻ظ´
ÇëÎÊÓÐÆÀÖ°³Æ£¬°Ñ¿ÆÑнÌѧҵ¼¨Ëã·ÖÅÅÐòµÄ¸ßУÂð
ÒѾÓÐ6È˻ظ´
Bioresource TechnologyÆÚ¿¯£¬µÚÒ»´Î·µÐÞµÄʱºò±»Í˻غü¸´ÎÁË
ÒѾÓÐ7È˻ظ´
Õæ³ÏÇóÖú£ºÊÖÀïµÄÊ¡Éç¿ÆÏîÄ¿½áÏîÒªÇóÖ÷³ÖÈËһƪÖÐÎĺËÐÄ£¬ÓÐʲôÇþµÀÄÜ·¢ºËÐÄÂð
ÒѾÓÐ8È˻ظ´
ѰÇóÒ»ÖÖÄÜ¿¸×¡Ç¿Ñõ»¯ÐÔ¸¯Ê´ÐÔµÄÈÝÆ÷ÃÜ·â¼þ
ÒѾÓÐ5È˻ظ´
ÇëÎÊÄÄÀï¿ÉÒÔÓÐÇàBÉêÇëµÄ±¾×Ó¿ÉÒÔ½è¼øÒ»Ï¡£
ÒѾÓÐ4È˻ظ´
ÇëÎÊÏ´ó¼ÒΪʲôÕâ¸öÁåľżÁª¼¸ºõ²»·´Ó¦ÄØ
ÒѾÓÐ5È˻ظ´
Ìì½ò¹¤Òµ´óѧ֣Áø´ºÍŶӻ¶Ó»¯Ñ§»¯¹¤¡¢¸ß·Ö×Ó»¯Ñ§»òÓлúºÏ³É·½ÏòµÄ²©Ê¿ÉúºÍ˶ʿÉú¼ÓÈë
ÒѾÓÐ4È˻ظ´
¿µ¸´´óѧ̩ɽѧÕßÖÜì÷»ÝÍŶÓÕÐÊÕ²©Ê¿Ñо¿Éú
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
¹ØÓÚSCI½ÓÊܺó¸Äµ¥Î»£¬Âé·³¸÷λ°ïæ¿´¿´
ÒѾÓÐ19È˻ظ´
SCI´óÐÞÖÐÓÐÒ»¸öÒâ¼û£¬ÎÒÕâô»Ø´ð²»ÖªµÀÐв»ÐУ¬»¹Óм¸¾äÓ¢ÎĻظ´£¬Çë¸ßÊÖ°ï¿´¿´£¡
ÒѾÓÐ4È˻ظ´
±¾È˵ÚһƪSCIÎÄÕ£¬±à¼µÄ»Ø¸´ÈÃÎÒ ¿´²»Ì«¶®
ÒѾÓÐ13È˻ظ´
µÚÒ»´ÎͶSCI£¬molecules£¬Assistant Editor »Ø¸´ÁËÎÒµÄÓʼþ£¬ÈçºÎ»Ø¸´Ëý£¿
ÒѾÓÐ10È˻ظ´
ÈçºÎ»Ø¸´SCIÎÄÕ£¬Çó°ï棡
ÒѾÓÐ9È˻ظ´
´ó¼Ò°ïæ¿´¿´£¬SCIУ¸åʱ±à¼·¢¹ýÀ´µÄÕâ¶Î»°µÄÒâ˼
ÒѾÓÐ9È˻ظ´
ÊÕµ½SCI½ÓÊÕÐÅ£¬ÈçºÎ»Ø£¿
ÒѾÓÐ10È˻ظ´
Çë¸÷λSCI´óÅ£¿´¿´¸ÃÉó¸åÒâ¼ûÈçºÎ»Ø¸´
ÒѾÓÐ3È˻ظ´
¹úÍâSCIÆÚ¿¯»Ø¹ýÀ´µÄÒâ¼û£¬ËÄÜ¿´Ã÷°×·´ÕýÎÒû¿´Ã÷°×¡£¡£¡£
ÒѾÓÐ41È˻ظ´
ͶEI»áÒéºóÊÕµ½SCIÆÚ¿¯ÑûÇ룬´ó¼Ò°ïæ¿´¿´¿¿Æ×ô£¿
ÒѾÓÐ10È˻ظ´
µÚһƪSCI±»¾Ü£¬¾À½áÒª²»ÒªÖØÍ¶£¬´ó¼Ò°ïæ¿´¿´
ÒѾÓÐ26È˻ظ´
sciÈçºÎ»Ø¸´Éó¸åÒâ¼û£¬ÓÈÆäÊǸĸñʽµÄÉó¸åÒâ¼û£¿
ÒѾÓÐ8È˻ظ´
µÚÒ»´Î·¢sciÆÚ¿¯£¬Çë°ïæ¿´ÏÂÆÀÉóÒâ¼û
ÒѾÓÐ20È˻ظ´
´ó¼Ò°ïæ¿´¿´£¬ÕâÖÖÇé¿öÈçºÎ»Ø¸´±à¼¼°ÉêËß
ÒѾÓÐ15È˻ظ´
ÓÐSCIͶ¸å¾ÑéµÄ³æÓѹýÀ´°ïæ¿´¿´Õâ¸öÎÊÌâÔõô½â¾ö°¡£¬Ò»Ö±Ã»ÊÕµ½proof
ÒѾÓÐ12È˻ظ´
ÇóÖú°¡£¬SCIÐÞ¸åºóÒ»ÔÂÓÐÓ࣬ѯÎʱ༣¬¸øÁËÒ»·â»ØÐÅ£¬´ó¼Ò°ïæ¿´Ò»ÏÂÊÇʲôÒâ˼°¡
ÒѾÓÐ24È˻ظ´
Ͷ¸åÓдð¸´ÁË£¬Ð©Ðí¼¤¶¯Çë´ó¼Ò°ïæ¿´¿´£¬Ð»Ð»´ó¼Ò£¡£¨ÔÚ13Â¥Ôö¼ÓµÚ¶þ·âÉó¸åÒâ¼û£©
ÒѾÓÐ32È˻ظ´
Çë´ó¼Ò°ïÎÒ¿´¿´Ôõô»Ø¸´ÕâÑùµÄproof,ÔÚÏߵȡ£¼±£¡
ÒѾÓÐ5È˻ظ´
µÚÒ»´ÎͶSCIÓöµ½ÁËһЩÎÊÌ⣬ϣÍû´ó¼ÒÄܸøÓè°ïÖú£¬Ð»Ð»ÁË¡£
ÒѾÓÐ6È˻ظ´
µÚÒ»´ÎͶSCI£¬²»ÖªµÀ±à¼µÄÕâ·â½ÓÊÕÀ´ÐÅÊÇ·ñÓ¦¸Ã»Ø¸´
ÒѾÓÐ11È˻ظ´
zdhbl
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 82.5
- Ìû×Ó: 23
- ÔÚÏß: 28.8Сʱ
- ³æºÅ: 1560352
- ×¢²á: 2012-01-02
- רҵ: ·¢ÓýÉúÎïѧ

2Â¥2014-07-22 23:07:56













»Ø¸´´ËÂ¥